Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Efficacy and Safety of Limited-Margin Conformal Radiation Therapy for Pediatric Rhabdomyosarcoma: Long-Term Results of a Phase 2 StudyChristopher L Tinkle, Alberto Pappo, Jianrong Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2010
Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groupsAndrea Ferrari, Rosalba Miceli, Annie Rey, et al.
Cold Spring Harbor Molecular Case Studies|August 7, 2021
Metastatic pediatric sclerosing epithelioid fibrosarcomaAndrew D Woods, Reshma Purohit, Laura Crocker Mitchell, et al.
The Lancet. Oncology|September 21, 2014
Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort StudyDaniel M Green, Wei Liu, William H Kutteh, et al.
NPJ Precision Oncology|May 16, 2025
Comparative analysis of RNA expression identifies effective targeted drug in myoepithelial carcinomaYvonne A Vasquez, Lauren Sanders, Holly C Beale, et al.
Journal of Cancer Survivorship : Research and Practice|January 21, 2022
Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcomaNina S Kadan-Lottick, Daniel J Zheng, Mingjuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Journal of Surgical Oncology|February 13, 2023
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG OncologyMark L Kayton, Aaron R Weiss, Wei Xue, et al.
Cancer Medicine|December 19, 2020
Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDouglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trialsSheri L Spunt, Nadine Francotte, Gian Luca De Salvo, et al.
Pageof 17